SCHEMBL23583147

SCHEMBL23583147

CCNc1cccn(-c2ccon2)c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 2/20 0.44
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
USP2 O75604 3/20 0.35
CASP1 P29466 2/20 0.35
CASP7 P55210 2/20 0.35
BRCA1 P38398 1/20 0.35
TP53 P04637 2/20 0.34
GRM1 Q13255 4/20 0.33
GAA P10253 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.32
POLB P06746 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
LMNA P02545 1/20 0.32
THRB P10828 1/20 0.32
CFTR P13569 1/20 0.32
APEX1 P27695 1/20 0.32
MAPK1 P28482 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20687710 0.84 TYK2 (0.47) TYK2TP53GAAALDH1A1MAPT
SCHEMBL20697035 0.81 TYK2 (0.44) TYK2GAAALDH1A1
SCHEMBL20687630 0.76 TYK2 (0.40) TYK2MEN1KMT2AUSP2CASP1
SCHEMBL21285310 0.76 TYK2 (0.45) TYK2MEN1KMT2AUSP2CASP1
SCHEMBL23583168 0.75 TYK2 (0.41) TYK2MEN1KMT2AUSP2CASP1
SCHEMBL20689554 0.74 TYK2 (0.44) TYK2ALDH1A1POLBLMNA
SCHEMBL16812511 0.73 TYK2 (0.44) TYK2TP53GAAALDH1A1
SCHEMBL20689552 0.71 TYK2 (0.44) TYK2CASP1CASP7TP53GAA
SCHEMBL20697237 0.70 ELANE (0.44) TYK2MEN1KMT2AUSP2CASP1
SCHEMBL21245957 0.70 TYK2 (0.43) TYK2MEN1KMT2AUSP2CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046698-B2 TYK2 inhibitors and uses thereof NIMBUS LAKSHMI, INC. (US) 2021-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11046698-B2 TYK2 inhibitors and uses thereof TYK2, JAK2, JAK1 TYK2 1/4885MEN1 2491/4885KMT2A 206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.